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Abstract
Background:  The co-morbidities of obesity are tied to location of excess fat in the intra-
abdominal as compared to subcutaneous white adipose tissue (WAT) depot. Genes distinctly
expressed in WAT depots may impart depot-dependent physiological functions. To identify such
genes, we prepared subtractive cDNA libraries from murine subcutaneous (SC) or intra-abdominal
epididymal (EP) white adipocytes.
Results: Differential screening and qPCR validation identified 7 transcripts with 2.5-fold or greater
enrichment in EP vs. SC adipocytes. Boc, a component of the hedgehog signaling pathway
demonstrated highest enrichment (~12-fold) in EP adipocytes. We also identified a dramatic
enrichment in SC adipocytes vs. EP adipocytes and in SC WAT vs. EP WAT for transcript(s) for the
major urinary proteins (Mups), small secreted proteins with pheromone functions that are
members of the lipocalin family. Expression of Boc and Mup transcript was further assessed in
murine tissues, adipogenesis models, and obesity. qPCR analysis reveals that EP WAT is a major
site of expression of Boc transcript. Furthermore, Boc transcript expression decreased in obese
EP WAT with a concomitant upregulation of Boc transcript in the obese SC WAT depot.
Assessment of the Boc binding partner Cdon in adipose tissue and cell fractions thereof, revealed
transcript expression similar to Boc; suggestive of a role for the Boc-Cdon axis in WAT depot
function. Mup transcripts were predominantly expressed in liver and in the SC and RP WAT depots
and increased several thousand-fold during differentiation of primary murine preadipocytes to
adipocytes. Mup transcripts were also markedly reduced in SC WAT and liver of ob/ob genetically
obese mice compared to wild type.
Conclusion: Further assessment of WAT depot-enriched transcripts may uncover distinctions in
WAT depot gene expression that illuminate the physiological impact of regional adiposity.
Background
In addition to its role in energy storage and mobilization,
white adipose tissue (WAT) is an important endocrine
organ that synthesizes and secretes various hormones and
adipokines, a number of which impact systemic energy
balance [1-4]. Various studies in humans and rodents
have illuminated distinctions in the physiology, lipolytic
response, gene expression and other aspects of adipocytes
present in different WAT depots [5-20]. These observa-
tions have led to the suggestion that individual WAT adi-
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pose depots are best regarded as separate "miniorgans"
[10]. These distinctions, and their molecular underpin-
nings, are gaining in importance with the realization that
it is the anatomical location of excess adipose tissue that
appears to underlie the health impact of obesity, and that
interventions targeting reduction of intra-abdominal fat
mass can effectively combat obesity-related diseases
[15,21-25]. Several recent studies have sought to identify
gene expression distinctions among preadipocytes or adi-
pocytes of different WAT adipose depots [19,20]. How-
ever, a complete and defining picture of WAT depot
dependent gene expression, as well as the underlying reg-
ulatory events governing depot-dependent gene expres-
sion, is yet to be identified.
In order to identify WAT depot-enriched transcripts, we
undertook preparation and screening of murine suppres-
sive subtractive hybridization (SSH) cDNA libraries
enriched for genes expressed in either SC or EP murine
adipocytes. Our studies reveal that transcripts for Mups,
major urinary protein members of the lipocalin super-
family with pheromone function, exhibit a surprisingly
distinctive pattern of transcript expression in WAT depots
with dramatic upregulation noted for subcutaneous (SC)
WAT and retroperitoneal (RP) WAT vs. the epididymal
(EP) intra-abdominal WAT depot. SSH screening also
identified 7 transcripts with enriched expression in EP adi-
pocytes vs. SC adipocytes. Of these, Boc, an immunoglob-
ulin superfamily member that functions in the hedgehog
signaling network, exhibited the highest degree of differ-
ential expression.
Methods
Animal use and cellular fractionation of murine adipose 
tissues
All animal treatments were conducted with the approval
of the University of Toledo Health Science Campus Insti-
tutional Animal Care and Use Committee. Mice were pur-
chased from The Jackson Laboratory. For Northern blot
and qPCR analyses of murine tissues, including in distinct
adipose depots, 8-wk old C57Bl/6J male mice were uti-
lized. For studies of gene expression in obese vs. wild type
mice, we used 8-wk old male mice that were ob/ob
homozygous on a C57Bl/6J background (strain designa-
tion, B6.V-Lepob/ob) or wild type C57Bl/6J mice generated
from breeding of ob/+ heterozygotes. Fractionation of
whole adipose tissue into adipocyte fraction (AF) and
stromal-vascular fraction (SVF) was via collagenase diges-
tion and differential centrifugation, as previously
described [26-28], starting with pooled tissue of 6 mice.
Resultant cell fractions were either used directly for RNA
preparation, or in the case of primary culture differentia-
tion studies (see below) SVF cells were plated and cultured
in DMEM with 10% FCS.
RNA preparation and transcript analysis
For analysis of transcript expression in murine adipose
depots, the SC, retroperitoneal (RP), and EP WAT and
interscapular brown adipose tissue (BAT) were dissected
from four individual 8-wk old male C57Bl/6J mice. Tis-
sues were minced, frozen in liquid nitrogen, and homog-
enized in TriZol reagent using a polytron. Other murine
tissues were similarly processed. Total RNA was purified
using TriZol reagent according to manufacturer's instruc-
tion (Invitrogen Corp.). For Northern blot analysis, 5 μg
of total RNA was fractionated in 1% agarose-formalde-
hyde gels in MOPS buffer and transferred to Hybond-N
membrane (GE Healthcare, Piscataway, NJ). Blots were
hybridized in ExpressHyb solution (BD Biosciences) for 1
h at 65°C with the indicated randomly primed 32P-dATP-
labeled cDNA insert probes. After washing for 20 min at
65°C with 1% SDS in 1× SSC and for 30 min at 65°C with
0.1% SDS in 0.1× SSC, membranes were exposed at -80°C
to Kodak BioMax film with a Kodak BioMax intensifying
screen. Northern blot analysis was conducted in duplicate
and representative data is shown. All lanes shown as a sin-
gle autoradiographic image were run on the same blot,
however in some instances lanes may have been reordered
or removed for economy and/or clarity of presentation.
For reverse-transcription and quantitative analysis of gene
expression by qPCR, total RNA was subject to purification
using an RNeasy kit with DNase I treatment (Qiagen
Corp., Valencia, CA) and cDNA synthesized with Super-
Script II RNase H(-) reverse transcriptase (Invitrogen
Corp.) using an oligo (dT)-22-mer primer. SYBR green-
based qPCR was conducted with an ABI 7500 Real-Time
PCR System (Applied Biosystems, Foster City, CA). Reac-
tion conditions were 1× SYBR Green PCR Master Mix
(Applied Biosystems), 100 nM each forward and reverse
primers, and 10 ng of cDNA. PCR was carried out over 40
cycles of 95°C for 15 sec, 60°C for 30 sec, and 72°C for
34 sec with an initial cycle of 50°C for 2 min and 95°C for
10 min. All primers were designed to span intron loca-
tions and qPCR assays were conducted in triplicate.
Primer sequences used were: Gapdh, 5'-GGCAAAT-
TCAACGGCACAG-3' and 5'-CGGAGATGATGAC-
CCTTTTGG-3'; 36B4 (gene name: acidic ribosomal
phosphoprotein P0/Arbp), 5'-GAGACTGAGTACACCT-
TCCCAC-3' and 5'-ATGCAGATGGATCAGCCAGG-3';
Boc, 5'-AAACAGCAGTGAGGCGAAC-3' and 5'-CACTT-
GGCAGGAGTCAGAAC-3'; Cdon, 5'-TAACATACT-
GAGCCCCCCACAG-3' and 5'-CACTACCATCGTCCAGC
TTTCG-3'; Mup1, 5'-AAGAACAAGCAAAGGGGCTGGG-3'
and 5'-ACACAGCAGCAGCAGCATCTTC-3'; Mup1/2, 5'-
ACTGACCCTAGTCTGTGTCC-3' and 5'-AGCCTTTTCT-
GTTTTGTCAGC-3'; Tuba1, 5'-GCAGCCGCGAAGCAG-
CAAC-3' and 5'-CCATGTTCCAGGCAGTAGAGCT-3';
Serping1, 5'-GTCCAAATTCCTGCCCACTTAC-3' and 5'-
TCAGTTCCAGCACTGTCTCG-3'; Timp4, 5'-TGGAAAAGBMC Genomics 2008, 9:397 http://www.biomedcentral.com/1471-2164/9/397
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TCTTCATCCATCTG-3' and 5'-GGTACATGGCACTGCAT
AG-3'; Col4a2, 5'-ACACTGTGGACTTACCAGG-3' and 5'-
CCAGGAAATCCAATGTCACC; H6pd, 5'-AGAAGAGCAG
TGCCATCCTG-3' and 5'-TCGATGTGGACAAGGACACC-
3'; Fos, 5'-CCCCAAACTTCGACCATGATG-3' and 5'-AGTT
GGCACTAGAGACGGAC-3'.
Specific transcript expression was normalized against
respective Gapdh and 36B4 signals and fold differences
calculated. Detection Gapdh or the 36B4 signals between
compared sample sets rarely differed by more than one or
two cycles. Graphical data is presented for transcript
expression levels calculated by correction to either Gapdh
or 36B4 internal control transcripts; these values are read-
ily apparent in the respective graph. However, for clarity
of presentation of data in the text, fold differences are pre-
sented as the average of the Gapdh and the 36B4 corrected
values. The p values stated in the text are applicable to
data generated with either correction for the Gapdh or
36B4 internal controls and only those data that meet the
criteria of statistically significant differential transcript
expression upon correction with both Gapdh and 36B4
are discussed in the text.
Suppression subtractive hybridization (SSH) and 
differential screening of SSH cDNA libraries
We employed the SSH method to generate subtractive
cDNA libraries for transcripts enriched in SC WAT adi-
pocytes or EP WAT adipocytes. SC WAT and EP WAT were
collected from six 8-wk old male C57Bl/6J mice. The SC
WAT and EP WAT from individual animals was pooled
and fractionated into adipocyte and SVF cell fractions via
collagenase digestion as previously described [26-28] and
total adipocyte RNA isolated using TriZol. A PCR-Select
cDNA Subtraction Kit (BD Biosciences, Palo Alto, CA) was
employed according to manufacturer instructions, to gen-
erate an SC adipocyte and an EP adipocyte SSH library,
starting from 5 μg of total RNA. The resultant pools of
PCR products consisting of double stranded cDNAs were
subcloned into the pGEM-T vector (Promega) and trans-
formed into DH5α E. coli to create SC SSH and EP SSH
plasmid-based libraries as E. coli stocks.
The SC adipocyte SSH cDNA library and EP adipocyte SSH
cDNA library were screened by differential hybridization
of high-density nylon cDNA arrays. Arrays were prepared
by robotic spotting of PCR-amplified inserts of SSH
library clones via contract arrangement with the German
Resource Center for Genome Research (RZPD, http://
www.imagenes-bio.de). The SSH library we prepared was
sent to RZPD as glycerol stock; RZPD plated the library
and robotically picked individual colonies and PCR
amplified clone inserts using PCR primers for sequences
flanking the pCR2.1-TOPO vector (Invitrogen Corp.)
multi-cloning site. PCR-amplified inserts were spotted in
duplicate from the SSH SC adipocyte and the SSH EP adi-
pocyte libraries to generate high density nylon arrays,
which were returned to us for differential screening. For
this, membranes were prehybridized at 65°C for 1 h in
ExpressHyb solution containing 20× SSC and 50 μg of
salmon sperm DNA and hybridized overnight at 65°C
using 33P-dATP-labeled reverse-transcribed probes synthe-
sized from 8 μg of EP adipocyte total RNA or SC adipocyte
total RNA. Following hybridization, membranes were
washed four times in 2× SSC/0.5% SDS at 65°C for 20
min each, followed by two 20 min washes in 0.2× SSC/
0.5% SDS at 65°C, after which they were exposed at -
80°C to Kodak BioMax film with a Kodak BioMax inten-
sifying screen. Signals were analyzed visually and candi-
date differentially expressed cDNAs were sequenced. Both
the fractionated material used to generate the SSH library
and that used to screen the library was validated for frac-
tionation into adipocyte and stromal fractions based on
expression of marker transcripts for these two fractions.
The adipocyte fraction was determined to be positive for
transcript expression of SCD1 and negative for TSC-36, a
marker we have identified for the SVF fraction of adipose
tissue [27]; the opposite pattern was observed for the SVF.
The adipocyte fraction was also negative for macrophages
and endothelial cells based on the lack of signal for emr1/
F80 and von Willebrand factor transcripts, respectively.
Adipocyte differentiation
3T3-L1 cells (American Type Culture Collection, Manas-
sas, VA) were propagated in DMEM supplemented with
10% calf serum. For differentiation, 3T3-L1 cells were
treated at two days post-confluence with DMEM supple-
mented with 10% FCS in the presence of the adipogenic
inducers 0.5 mM methylisobutylxanthine (MIX) and 1
μM dexamethasone for 48 h. Adipogenic agents were then
removed, and growth of cultures continued in DMEM
containing 10% FCS. At five days post-induction of differ-
entiation, adipocyte conversion had occurred in approxi-
mately 90% of the cells, as judged by lipid accumulation
and cell morphology.
Murine primary preadipocyte SVF cultures were prepared
from SC WAT of 8-wk old C57Bl/6J male mice, as
described under Animal Use and Cellular Fractionation of
Murine Adipose Tissues, above. Cells were propagated in
DMEM supplemented with 10% FCS. For differentiation,
cultures were treated at two days post-confluence with
DMEM supplemented with 10% FCS in the presence of
the adipogenic inducers 0.5 mM MIX, 1 μM dexametha-
sone, 0.2 mM indomethacin, and 170 nM insulin for 72
h. Adipogenic agents were then removed and growth of
cultures continued in DMEM containing 10% FCS. Pri-
mary cell differentiation was analyzed on two sets of cul-
tures with essentially the same results.BMC Genomics 2008, 9:397 http://www.biomedcentral.com/1471-2164/9/397
Page 4 of 14
(page number not for citation purposes)
Results
Differential enrichment of Boc and Cdon transcripts in EP 
adipocytes and EP WAT
Given the relationship between regional adiposity and
health morbidities we set out to identify transcripts that
evidenced enriched expression in specific WAT depots by
creating and screening SSH cDNA libraries designed to be
enriched for transcripts present in EP or SC adipocytes.
Genes that were identified in our SSH screening showing
differential transcript expression in EP adipocytes vs. SC
adipocytes were validated by qPCR. Of these, Boc demon-
strated the greatest degree of transcript enrichment in EP
adipocytes vs. SC adipocytes. Boc is a binding partner for
Cdon, also known as cell adhesion molecule-related/
down-regulated by oncogene [29,30]. Boc and Cdon are
both immunoglobulin superfamily members that are
components of the hedgehog signaling pathway [29,30].
qPCR analysis in Figure 1A shows that Boc transcript is
enriched an average 12-fold (p < 0.001) in EP adipocytes
vs. SC adipocyte and an average 32-fold (p < 0.001) in the
EP SV cell fraction vs. SC SV cell fraction. When intact adi-
pose tissue is assessed, Boc transcript shows an average 27-
fold (p < 0.001) enrichment in EP WAT vs. SC WAT (Fig-
ure 1B). Boc transcript level similar to that for SC is noted
in RP WAT and BAT. These data suggest that it is not solely
the adipocytes in EP adipose tissue that are enriched for
Boc transcript, but that enrichment is also found for cell
type(s) in the SV fraction. We next examined whether a
similar pattern of expression might be noted for transcript
for the Boc binding protein Cdon. We find that Cdon
transcript is also enriched in EP WAT vs. SC WAT,
although this is only noted for the SV fraction (Figure 1C)
or intact WAT (Figure 1D), and not for isolated adipocytes
(Figure 1C). As Boc and Cdon transcripts were both
detected in adipocytes we also tested whether their tran-
script expression level was altered in adipogenesis by
assessing levels in 3T3-L1 cells, a well characterized model
of in vitro adipocyte differentiation, and in the in vitro dif-
ferentiation of primary preadipocytes to adipocytes. In
both cases, the levels of Boc and Cdon transcripts were not
appreciably different in preadipocytes vs. in vitro differen-
tiated adipocytes (data not shown).
Since neither the expression of transcripts for Boc nor
Cdon had been previously assessed in adipose tissue, but
the hedgehog pathway plays a role in fat formation [31-
33], we next determined transcript expression in wild type
and obese (ob/ob) murine adipose tissues by qPCR (Figure
2). We find that alteration of Boc transcript level occurs in
each of the 4 depots examined, with ob/ob mice showing
upregulation of Boc transcript in SC, RP and BAT, and
downregulation in EP (Figure 2A). Thus we find that for
ob/ob, Boc transcript depot-dependence in SC vs. EP WAT
is opposite to that observed for wild type WAT depots,
namely SC ob/ob WAT shows the highest degree of expres-
sion of Boc transcript is an average 2.5 times (p < 0.001)
that found in ob/ob EP WAT. For Cdon, upregulation of
transcript is noted in ob/ob vs. WT for the SC and BAT
depots of an average 1.6-fold (p < 0.01) and 4-fold (p <
0.001), respectively (Figure 2B). To our knowledge, only
limited assessment of murine tissue expression patterns
have been reported for Boc and Cdon transcript, and stud-
ies assessing expression in adipose tissue vs. other tissues
have not been carried out. To determine if EP WAT is a
dominant site of expression of these genes in vivo, we used
qPCR to compare Boc and Cdon transcript levels in kid-
ney, testis, lung, heart, brain, spleen, muscle and liver with
that for EP WAT (Figure 3). EP WAT was chosen for this
comparison, since it expressed the highest level of Boc
transcript of the four adipose depots we had examined
(Figure 1). Of the nine murine tissues examined, EP WAT
was the site of highest expression of Boc transcript (Figure
3A) and it was among the highest site for expression of
Cdon transcript (Figure 3B). Future work from this labo-
ratory will address the functional role Boc and Cdon may
play in distinct WAT depots.
Data for the other 6 genes that we identified as enriched
in EP vs. SC adipocytes are presented in Additional file 1.
However, these do not meet a criteria of statistically signif-
icant (p < 0.01) of EP vs. SC depot enriched expression for
isolated adipocytes as well as in whole EP vs. SC WAT. For
example, Fos is only minimally expressed in whole WAT
of either the SC or EP depot, but its level is dramatically
elevated in response to the isolation procedure per se, as
has been described for a number of genes [34].
Differential screening reveals highly enriched expression of 
Mup transcripts in the SC WAT depot
Our analyses of differential hybridization of SSH SC
library clones revealed that approximately 50 of the cDNA
clones with increased expression in SC adipocytes vs. EP
adipocytes contained sequences corresponding to major
urinary protein. Major urinary proteins (Mups) are small
acidic molecules with molecular mass of ~19 kDa that
belong to the lipocalin superfamily [35]. Lipocalins share
a novel conserved calyx-shaped β barrel structure [36-44]
and proteins in this family are proposed to serve dual
molecular functions in the transport of lipophilic mole-
cules and in the regulation of cell homeostasis [45]. Mups
exist as a complex array of protein isoforms generated
from the multigene Mup gene family present on murine
chromosome 4 [46]; they are present in serum and are the
major protein constituent of urine in the mouse [47]. The
Mup gene family includes functional genes, pseudogenes
and silent genes [48-57]; our recent analysis of the
Ensembl database http://www.ensembl.org indicated 44
gene sequences in this family. Only a handful of Mup
genes and gene products have been characterized in any
detail, mainly Mup1 – Mup5 [58]. The most recent studiesBMC Genomics 2008, 9:397 http://www.biomedcentral.com/1471-2164/9/397
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Figure 1
Expression of transcripts for hedgehog signaling components Boc and Cdon in adipose depots. A. qPCR assess-
ment of transcript levels in SVF and AD fractions of SC and EP WAT using the Boc primer set. B. qPCR assessment of Boc 
transcript in whole SC, EP, RP or BAT adipose tissue. C. qPCR assessment of transcript levels in SVF and AD of SC and EP 
WAT using the Cdon primer set. D. qPCR assessment of Cdon transcript in whole SC, EP, RP or BAT adipose tissue. For A-
D, the left panels show data corrected against Gapdh and the right panels show data corrected against 36B4 as internal control 
for qPCR analysis; values stated in the text are the average of the Gapdh-corrected and 36B4-corrected data for each compar-
ison. In A and B, the level in SC AD was set to a value of 1. SVF, stromal vascular fraction; AD, adipocyte fraction. In B and D, 
the level in SC WAT was set to a value of 1. For A, * indicates p < 0.001 for EP SVF vs. SC SVF and for EP AD vs. SC AD and # 
indicates p < 0.001 for EP SVF vs. all others (both panels). For B, * indicates p < 0.001 for EP vs. all others. For C, * indicates p 
< 0.001 for EP SVF vs. all others (both panels). For D, * indicates p < 0.001 for EP vs. all others (left panel) and EP vs. SC and 
BAT (right panel).BMC Genomics 2008, 9:397 http://www.biomedcentral.com/1471-2164/9/397
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of Mup transcripts expression were conducted roughly
two decades ago [48-57], when the extent of gene
sequence similarity and complexity of the Mup gene fam-
ily was likely not fully appreciated. Mup gene expression
has not been reported to any extent in the intervening
time period. In retrospect, it is unclear if single specific
Mup transcript species, or rather sets of Mup transcripts,
were truly under study in earlier reports.
An extremely high degree of identity is found in the
sequences of various Mup transcripts with difference in
sequence among members of the Mup multigene family
often occurring as only scattered single or several base var-
iations [59]. As such, the nearly identical nucleotide
sequences of a number of different Mup gene products,
particularly those with a high degree of identity with
Mup1 and Mup2, render a number of Mup transcripts vir-
Expression of Boc and Cdon transcript in wild type and ob/ob tissues Figure 2
Expression of Boc and Cdon transcript in wild type and ob/ob tissues. qPCR assessment of transcript level in wild type 
C57Bl/6J (WT) and ob/ob SC WAT, EP WAT, RP WAT and BAT depots using the Boc primer set (A) and the Cdon primer set 
(B). For A and B, the left panels show data corrected against Gapdh and the right panels show data corrected against 36B4 as 
internal control for qPCR analysis; values stated in the text are the average of the Gapdh-corrected and 36B4-corrected data 
for each comparison. The level in WT BAT was set to a value of 1. For A, * indicates p < 0.001 for comparisons of WT vs. ob/
ob samples for each of SC, EP, RP and BAT and # indicates p < 0.005 for ob/ob SC vs. all other ob/ob samples, and **, P < 0.005 
for WT EP vs. all other samples (both panels). For B, * indicates p < 0.001 for WT vs. ob/ob BAT WT (both panels) and for WT 
vs. ob/ob for SC and EP depots left panel only.BMC Genomics 2008, 9:397 http://www.biomedcentral.com/1471-2164/9/397
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tually indistinguishable by either Northern blot or PCR-
based methods. Nonetheless, in an attempt to more pre-
cisely investigate the nature of differential Mup transcript
expression, we designed PCR primer pairs that would be
predicted to distinguish the gene products of Mup1 and of
4 Mup1-related genes from that for other Mup sequences;
Mup1 and a subset of Mup1-related genes contain a
unique region of ~40 nucleotides at the 5' end of the
respective transcript(s). The qPCR data employing the
Mup1 PCR primer set on fractionated WAT tissues is
shown in Figure 4A and indicates higher Mup transcript
expression in the SC depot compared to the EP depot. The
signal detected with the Mup1 primer set is an average 560
times higher (p < 0.001 in SC SV fraction than in the EP
SV fraction) and an average 100-fold higher (p < 0.001) in
the SC AD fraction than in the EP AD fraction. To further
discern adipose tissue expression of Mup transcripts, we
utilized a second primer set, designated Mup1/2. Based
on our assessment of the Mup multigene family, the
Mup1/2 primer set is predicted to detect the same set of
Mup transcripts detected by the Mup1 primer set, and 11
additional Mup transcripts, including Mup2. Compared
with the signal from the Mup1 primer set, wherein tran-
scripts are highly enriched in the SC SV fraction, tran-
scripts detected with the Mup1/2 primer set are greatly
enriched in the SC AD fraction. Here, the SC AD fraction
signal is an average 70-fold higher (p < 0.001) than the SC
SV fraction. Enrichment of signal in the SC vs. the EP
depot is also evident. The signal in the SC AD fraction is
an average 880-fold higher (p < 0.001) than in the EP AD
fraction and the SC SV fraction signal is an average 1100-
fold higher (p < 0.001) than the EP SV fraction.
When levels in whole adipose tissue are examined with
the Mup1 primer set (Figure 4C), compared to EP WAT,
an average 13-fold higher (p < 0.001) level of transcript is
noted for SC WAT and an average 48-fold higher (p <
0.001) for the RP depot. Interestingly, although RP WAT
is also intra-abdominal in location, it nonetheless
expresses Mup transcript(s) at an order of magnitude that
is similar to that noted for the SC WAT depot. Figure 4D
shows that, similar to our findings with the Mup1 primer
set, the Mup1/2 primer set detects enrichment of Mup
transcripts in SC WAT and RP WAT. However, here we
find that compared with the EP WAT, an average 43-fold
higher (p < 0.001) level of transcript expression is noted
for SC WAT and an average 270-fold higher (p < 0.001)
level of transcript expression for the RP WAT depot (p <
0.001). Although the overall pattern of Mup transcript
expression noted with the Mup1 and Mup1/2 primer sets
is similar, these data also suggest a greater degree of depot-
differential Mup transcript expression is found within that
population of transcripts detected with the Mup1/2
primer set. We also conducted Northern blot analysis on
SC and EP WAT of four individual mice using the Mup1
sequence as probe and included hybridization for the adi-
pocyte marker transcripts aFABP and SCD1 for compari-
son purposes. Due to the high degree of sequence
similarity and transcript size among various Mups, this
analysis would be predicted to examine a population of
various Mup transcripts. The Northern blot in Figure 4E
(top panel) indicates clearly higher expression of signals
detected by the Mup1 probe in the SC WAT depot, with a
dramatically lower signal for EP WAT. The lower panel of
Figure 4E reveals that in fractionated SC and EP WAT, it is
the SC adipocytes that show the highest expression of sig-
nals detected by the Mup1 probe.
Since our data illustrated enrichment of Mup transcript in
adipocytes vs. SV fraction cells, wherein preadipocytes are
found, we next examined whether upregulation of Mup
Tissue distribution of Boc and Cdon transcript expression Figure 3
Tissue distribution of Boc and Cdon transcript 
expression. qPCR analysis using the Boc (A) or the Cdon 
(B) primer set. For A and B, data was corrected against 
Gapdh (black fill) and or 36B4 (white fill) as internal control 
for qPCR analysis; values stated in the text are the average of 
the Gapdh-corrected and 36B4-corrected data for each 
comparison. For A, * indicates p < 0.001 for EP WAT com-
pared with all tissues except the Gapdh-corrected value for 
lung. For B, * indicates p < 0.001 for EP WAT compared with 
all tissues except the Gapdh-corrected value for lung and the 
36B4-corrected value for brain. For A and B, the level in kid-
ney was set to a value of 1.BMC Genomics 2008, 9:397 http://www.biomedcentral.com/1471-2164/9/397
Page 8 of 14
(page number not for citation purposes)
Figure 4
Differential enrichment of Mup transcripts in the SC WAT depot. A. qPCR assessment of transcript levels in SVF and 
AD fractions of SC and EP WAT using the Mup1 primer set. SVF, stromal vascular fraction; AD, adipocyte fraction. B. qPCR 
assessment of transcript levels in SVF and AD of SC and EP WAT using the Mup1/2 primer set. C. qPCR assessment of whole 
SC, EP, RP or BAT adipose tissue using the Mup1 primer set. D. qPCR assessment of whole SC, EP, RP or BAT adipose tissue 
using the Mup1/2 primer set. For A the EP SVF signal level was set to a value of 1 and for B the EP AF signal was set to 1. For 
A, * indicates p < 0.001 for SC SVF vs. EP SVF and for SC AD vs. EP AD, and # indicates p < 0.01 for SC SVF vs. all others. For 
B, * indicates p < 0.001 for SC SVF vs. EP SVF and for SC AD vs. EP AD, and # indicates p < 0.001 for SC AD vs. all others. For 
C and D the signal level in BAT was set to 1 and * indicates p < 0.001 for SC or RP compared with EP and with BAT. E. Upper 
panel shows Northern blot analysis of depot-dependent gene expression in either SC WAT or EP WAT depots of four individ-
ual male C57Bl/6J mice using 32P dATP-labeled Mup1, aFABP or SCD1 hybridization probes. Lanes 1–4 and lanes 5–8 represent 
SC and EP WAT tissue from mouse #1, #2, #3 and #4, respectively. Lower panel shows Northern blot analysis of fractionated 
SC and EP WAT. SV, stromal vascular fraction; AF, adipocyte fraction. Ethidium bromide staining of rRNA is shown as gel load-
ing control. F. and G. qPCR assessment for 3T3-L1 or primary cultures of preadipocytes (Pre) and adipocytes (Adi) using the 
Mup1 (F) or the Mup1/2 (G) primer sets. The level of transcript expression in primary preadipocytes was set to a value of 1. 
For F and G, * indicates p < 0.001 for primary adipocytes vs. all others. For A-D, F and G, the left panels show data corrected 
against Gapdh and the right panels show data corrected against 36B4 as internal control for qPCR analysis; values stated in the 
text are the average of the Gapdh and 36B4-corrected data for each comparison.BMC Genomics 2008, 9:397 http://www.biomedcentral.com/1471-2164/9/397
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transcripts accompanied adipogenic conversion. qPCR
analysis with the Mup1 and Mup1/2 primer sets revealed
low levels of transcript expression in 3T3-L1 preadi-
pocytes that were not appreciably altered during their con-
version to adipocytes (Figure 4F and 4G). Therefore we
next tested the differentiation-dependent expression of
Mup transcripts using primary preadipocyte cultures pre-
pared directly from murine SC WAT, and which might
therefore be more reflective of the in vivo setting. Use of
the Mup1 primer set, shown in Figure 4F, indicates an
average 8-fold (p < 0.001) increase occurs during adipo-
genesis of primary cultures. Use of the Mup1/2 primer set
(Figure 4G), reveals an average 5200-fold (p < 0.001)
increase in level of transcript(s) detected by this primer
set.
Dysregulation of Mup transcript expression in WAT of ob/
ob genetically obese mice
To examine whether Mup transcript(s) expression was
altered in obesity we utilized the ob/ob genetic model of
murine obesity and compared expression with that of
wild type mice. qPCR data obtained with the Mup1 and
Mup1/2 primer sets are shown in Figures 5A and 5B. For
the Mup1 primer set, compared with SC WAT and RP WAT
from ob/ob mice, we find an average 10-fold (p < 0.001)
higher transcript level in wild type SC WAT and an average
26-fold (p < 0.001) higher level for wild type RP WAT. For
the Mup1/2 primer set, compared with SC WAT and RP
WAT of ob/ob mice, we note an average 60-fold (p < 0.001)
higher transcripts expression for wild type SC WAT and an
average 230-fold (p < 0.001) higher level of transcripts for
wild type RP WAT (p < 0.001). The Northern blot wherein
the Mup1 sequence was used as a probe (Figure 5C)
reveals a lack of Mup transcript signal in SC, EP, RP and
BAT of WAT of ob/ob mice. Our findings indicate that Mup
transcript(s) evidence differential expression not only
across WAT depots, but also in respect to a well-estab-
lished genetic model of murine obesity. That we find a dif-
ferential degree of Mup transcript(s) enrichment in
C57Bl/6J wild type and ob/ob mice when we use the Mup1
primer set vs. the Mup1/2 primer set suggests that within
the Mup multigene family there are distinctions regarding
the influence of obesity on the degree of differential
expression of particular Mup transcript(s).
Mup transcript expression in murine tissues
Previous studies indicated that Mup transcript expression
appeared particularly enriched in livers and also in other
select tissues with secretory function; adipose tissue is
now recognized as a secretory organ [1,60]. To examine
the relative expression of Mup transcript(s) in adipose tis-
sues vs. other murine tissues, we conducted qPCR and
Northern blot analysis. SC WAT was chosen as a positive
control for these comparisons since it expressed readily
detected levels of Mup transcripts both by qPCR and
Northern blot (Figures 4 and 5). Figure 6 shows qPCR
analysis for the level of transcript(s) expression detected
with the Mup1 (Figures 6A and 6B) or Mup1/2 primer set
(Figures 6C and 6D). The Mup1 primer set (Figure 6A)
detects an average 350-fold (p < 0.001) higher signal in
liver vs. SC WAT and the Mup1/2 primer set (Figure 6C)
an average 25-fold (p < 0.01) enrichment in liver com-
pared to SC WAT. Figures 6B and 6D assess Mup tran-
script(s) expression in SC WAT and a panel of other
murine tissues. For the Mup1 primer set (Figure 6B), a
Reduced expression of Mup transcript(s) in WAT of ob/ob  mice Figure 5
Reduced expression of Mup transcript(s) in WAT of 
ob/ob mice. A. qPCR assessment of transcript level in wild 
type (WT) and ob/ob (ob) SC WAT and RP WAT depots 
using the Mup1 primer set. B. qPCR assessment of transcript 
level in WT and ob SC WAT and RP WAT depots using the 
Mup1/2 primer set. For each graph, the signal in the respec-
tive WT tissue was set to a value of 100. For A and B the left 
panel shows data corrected against Gapdh and the right 
panel show data corrected against 36B4 as internal control 
for qPCR analysis; values stated in the text are the average of 
the Gapdh-corrected and 36B4-corrected data for each 
comparison. For A and B, * indicates p < 0.001 for WT SC vs. 
ob SC and for WT RP vs. ob RP. C. Northern blot analysis of 
5 μg of total RNA from the indicated WAT depot or BAT 
from WT or ob/ob mice. Blot was hybridized to Mup1, aFABP 
or SCD1 32P dATP-labeled probes. Ethidium bromide stain-
ing of rRNA is shown as a gel loading control.BMC Genomics 2008, 9:397 http://www.biomedcentral.com/1471-2164/9/397
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roughly similar level of expression is noted for SC WAT
and all other tissues with the exception of spleen, which
evidences minimal expression. In contrast, a different pat-
tern of Mup transcript(s) expression is noted with the
Mup1/2 primer set (Figure 6D), with SC WAT evidencing
the highest expression. The differential nature of the sig-
nals obtained with the Mup1 and Mup1/2 primer sets sug-
gests that among the multiple Mup transcript populations
we detect herein, a number of individual Mup transcripts
likely evidence distinctive patterns of tissue restricted
expression. The Northern blot in the upper panel Figure 7
reveals that while liver tissue exhibits strongest signal
detectable upon hybridization with the Mup1 probe, that
of the tissues tested SC WAT is also a predominant site of
expression of Mup transcripts. Since we note that the
highest signal detected by the Mup1 probe are in liver, we
also examined whether the level of these transcript was
reduced in the liver of ob/ob, has we had previously
found for SC and RP adipose tissue in such mice. The
Northern blot in the lower panel of Figure 7 indicates a
marked reduction of Mup transcripts in the liver of ob/ob
vs. wild type mice.
Discussion
The link between regional adipocyte burden and health
morbidities is becoming increasingly apparent and thus it
is key to reach beyond studies of adipogenesis per se, into
studies that describe and explain gene expression in either
the adipocyte and/or non-adipocyte cellular component
of specific WAT depots. Such studies, however, are
dependent on the discovery and validation of model
genes that show a robust adipocyte depot-dependent phe-
notype. Our data herein and the work of others [19,20,61]
have identified genes with differential pattern(s) of
expression in regard to WAT depot expression. Kahn and
colleagues recently used DNA microarray chips to assess
transcript expression in adipocytes and SVF cells from
murine SC WAT and EP WAT depots [19]. They identified
197 transcripts that met their criteria of differential expres-
sion for both adipocytes and SVF from SC WAT vs. EP
WAT; the vast majority of the reported genes were altered
less than 3-fold [19]. Interesting insights into the nature of
WAT depot-dependent gene expression were, however,
revealed in their further analysis of WAT depot-dependent
expression of 12 embryonic development and pattern
specification genes [19]. In these cases, the depot-depend-
ence appeared cell autonomous in nature and was also
observed for human WAT samples. Furthermore, the tran-
script levels of a subset of the 12 genes correlated with
waist-to-hip ratio and/or body mass index, two estab-
lished indices of human regional adiposity [19]. These
workers also found differential expression of Mup tran-
scripts in the SC WAT depot (74-fold higher in SC vs. EP);
however as Mup transcript(s) were not among the small
subset of developmental and/or patterning genes that
qPCR analysis of tissue distribution of Mup transcript(s)  expression Figure 6
qPCR analysis of tissue distribution of Mup tran-
script(s) expression. qPCR analysis using the Mup1 primer 
set (A and B) or the Mup 1/2 primer set (C and D). For A 
and C the SC WAT level was set to a value of 1. For B and D 
the transcript level in spleen was set to a value of 1. For A – 
D, data was corrected against Gapdh (black fill) and or 36B4 
(white fill) as internal control for qPCR analysis; values stated 
in the text are the average of the Gapdh-corrected and 
36B4-corrected data for each comparison. For A and C, * 
indicates p < 0.001 for liver vs. SC WAT. For D, * indicates p 
< 0.05 for SC WAT vs. all others.
Northern blot analysis of Mup transcript expression in  murine tissues Figure 7
Northern blot analysis of Mup transcript expression 
in murine tissues. Northern blot analysis of a panel of 
C57Bl/6J murine tissues hybridized with a 32P dATP-labeled 
Mup1 probe. Lower panel shows Northern blot analysis of 
liver tissue from two wild type (WT) and two ob/ob mice. 
Ethidium bromide staining of rRNA is shown as a gel loading 
control.BMC Genomics 2008, 9:397 http://www.biomedcentral.com/1471-2164/9/397
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were the focus of their study, its expression was not further
validated or examined. Additionally, both our study and
theirs observed increased expression of enrichment of
tubulin alpha 1 transcript in the EP white adipose cells
and tissue depot compared to that for SC [19]. It should
also be kept in mind that these studies have examined
transcript levels and whether the corresponding protein
levels show differential expression remains to be deter-
mined. That we did not identify a larger set of differen-
tially-expressed genes in common with the Kahn study
[19], may be due to relative differences in sensitivity and/
or comprehensiveness of the experimental methods
employed. It is unlikely to be due to sample preparation
as we have since assessed our RNA preparations for three
depot-enriched transcripts identified by Kahn and cow-
orkers [19] and found results similar to those they
reported. Namely, levels of transcripts for Tbx15 and
Shox2 were markedly higher in EP WAT than SC WAT and
that for Phldb2 was higher in SC WAT than EP WAT (data
not shown).
Uncovering gene expression distinctions across WAT
depots have the potential to elucidate the underlying
mechanism(s) for the development and/or function of
specific adipose depots, and cell types therein, and their
relation to disease. Comparison of the transcriptomes of
visceral vs. subcutaneous adipocytes from WAT might ulti-
mately provide therapeutic interventions that target vis-
ceral adipocytes while sparing white adipocytes in other
WAT depots. While these types of gene expression studies
are relatively straightforward, they also carry an important
caveat. It has been clearly documented that the standard
collagenase isolation procedure, which is necessary to sep-
arate whole adipose tissue into adipocyte and other cellu-
lar fractions, in itself, results in marked alterations in gene
expression [34]. This is attributed in part to the impact of
released cytokines, such as TNFα, and other factors from
adipose tissue cell components on adipocyte and/or SVF
cell gene expression [34]. Such concerns apply to our
investigation as we produced and screened our subtracted
libraries using the isolated adipocyte component of SC
and EP WAT depots. However, we utilized both fraction-
ated and whole adipose tissue samples for the detailed
qPCR validation of depot-differential expression, and
found that differential expression of Boc and Mup
occurred both when isolated cell fractions and whole adi-
pose tissue depots were assessed. On the other hand, the
expression level of Fos transcript (see Additional file 1) is
1000 times higher in the fractionated cell samples vs.
intact adipose tissue; Fos is therefore an example of a gene
whose expression is dramatically altered due to the colla-
genase digestion protocol. Another concern that arises in
regard to qPCR studies is that transcript expression is cal-
culated relative to an internal control standard [62-64];
which by definition is expressed at a consistent level
regardless of experimental conditions or cell/tissue types
under study. For example, actin is described to decrease
during adipogenesis, and as such would not be an appli-
cable internal control in such studies [65]. We show
herein that, overall, our differential gene expression data
for EP vs. SC WAT depot at the cell and tissue level is of a
similar magnitude when either Gapdh or acidic ribosomal
phosphoprotein P0 (36B4) is used as an internal stand-
ard. This suggests that our findings are of a robust nature
and not solely reflective of variation in expression of a sin-
gle given internal control transcript across the analyzed
samples.
While we do not at this time know the regulatory mecha-
nisms behind the reduction of Mup transcript expression
in ob/ob mice, it is of interest to note that reduced fertility
occurs in the ob/ob mouse [66,67]. Mups are lipocalins
that function as pheromones, either alone or when bound
to small hydrophobic molecules [68,69] and are impor-
tant in reproductive cycle of rodents where urine-derived
signals control sexual attraction, mating and puberty
onset [70-73]. As pheromones, Mup proteins control mat-
ing behavior and puberty onset in mice; reduced Mup
transcript levels in ob/ob mice may conceivably be related
to their infertility phenotype [66,67]. In this regard Mup
expression, at least in mice, may be a molecular avenue
whereby fat mass or fat distribution might impact mating
and fertility. While it is unfortunate that the nearly similar
sequence of a number of the Mup genes precludes a pre-
cise gene-by-gene analysis of each individual Mup tran-
script in this complex multigene family [48-57],
nonetheless future studies on the nature and adipose
depot specificity of the Mup gene(s) promoter regions
may allow a more precise mapping and understanding of
Mup gene expression and regulation in distinct WAT
depots. There are no known close functional or sequence
analogs of Mups in humans, with the odorant binding
proteins the most closely related human proteins [74,75].
However, several lipocalin family members play roles in
murine and/or human adipose tissues. For example,
lipocalin-2, also known as neutrophil gelatinase associ-
ated lipocalin (NGAL) transcript and protein increases
during in vitro adipogenesis of 3T3-L1 preadipocytes and
is abundantly expressed in adipose tissue [76-78]. Circu-
lating lipocalin-2 concentrations positively correlate with
adipocyte mass, hypertriglyceridemia, hyperglycemia and
insulin resistance [78-80]. The lipocalin retinol binding
protein 4 (RBP4) has recently been reported to be a
marker for abdominal fat mass in humans [81] and some
studies have suggested a role for RBP4 in the pathogenesis
of type 2 diabetes [82-87].
In the case of EP WAT, we find Boc transcript to show dif-
ferential enrichment in EP vs. SC WAT when compared in
purified adipocytes, stromal vascular fraction, as well as inBMC Genomics 2008, 9:397 http://www.biomedcentral.com/1471-2164/9/397
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intact WAT depots. Boc acts as a receptor for sonic hedge-
hog and is important for the guidance of commissural
axons [88]. The Cdon and Boc complex also mediates cell-
cell interactions between muscle precursors to promote
myogenesis [89]. Hedgehog signaling is a very early event
in the onset of adipogenesis [33]. Since myocytes and adi-
pocytes are believed to share the same mesodermal pro-
genitor cell type [90] and the hedgehog signaling pathway
has been demonstrated to have an important role in fat
formation [31-33], it is possible that Boc is involved in
adipogenesis and/or adipocyte function. To our knowl-
edge our findings on Boc transcript expression in WAT
depots and the upregulation of Boc transcript in ob/ob
WAT are the first to suggest a role for Boc in adipose tissue.
At the least, our observations indicate that the function of
Boc, and possibly its binding partner Cdon, should be
considered in models that address the role of the hedge-
hog pathway in adipose tissue.
Conclusion
It is possible that additional dissection of the mechanisms
underlying the enrichment of Mup transcripts in the SC
WAT depot and Boc transcript in the EP WAT depot may
lead to novel insights on the molecular mechanisms gov-
erning gene expression in distinct WAT depots, for which
very little knowledge currently exists. Studies along these
lines may ultimately, for example, result in the design of
promoter constructs that would allow for transgenesis or
knockout studies to be conducted in a WAT depot-
dependent manner. Future analyses of the transcriptional
control of WAT depot specific gene regulation may also
lead to key insights into regional adiposity and pinpoint
WAT depot-specific therapeutic intervention targets in the
fight against obesity and its complications.
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